♟️ Monday 20 October 2025 Mon, 20 Oct 2025

Yancoal’s September quarter report reveals stable coal output and a slight dip in realised prices, alongside a leadership change and strategic stake increase in the Moolarben Joint Venture.

Vonex Limited has finalized its Scheme of Arrangement, transferring all shares to Maxo Telecommunications and initiating a board overhaul ahead of its imminent ASX delisting.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Chalice Mining is progressing its Gonneville Project Pre-Feasibility Study on schedule for November 2025 completion, fully funded and targeting a Final Investment Decision by late 2027 as palladium prices hit a two-year high.

United States Antimony Corporation has proposed acquiring Larvotto Resources in a deal that could create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium.

EV Resources has secured a 150-tonne-per-day processing plant near its Los Lirios project, fast-tracking antimony production and positioning itself as a key North American supplier.

Jindalee Lithium has launched an options offer linked to its recent Share Purchase Plan and placements, aiming to incentivize shareholders and raise capital for its lithium development projects. The options carry an exercise price of $0.825 and expire in late 2028.

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

PolyNovo Limited reported a robust 33.3% increase in Q1 FY26 sales, driven by strong U.S. growth and a remarkable surge in NovoSorb MTX sales. The company also completed key infrastructure projects, positioning itself for further expansion.

Singular Health Group has advanced its US expansion through the deployment of 3DICOM™ licenses under a key contract with Provider Network Solutions, alongside appointing a new US commercial chief to drive growth.

Australian Strategic Materials secures A$50.8 million via share placement to fund Korean plant expansion and advance US metals project, while navigating complex supply chain and funding risks.

ASM Limited has raised A$55 million to accelerate production capacity at its Korean Metals Plant and expand its footprint in the rare earths sector, responding to growing global demand and geopolitical supply chain pressures.

True North Copper has appointed Andrew Mooney as Managing Director, signaling a strategic shift towards advanced exploration and project development in Queensland.

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

Bapcor reports a 2.7% revenue decline in 1Q26 and outlines a comprehensive operational review and cost-saving plan, setting cautious guidance for FY26.

Deep Yellow Ltd announces the departure of long-serving CEO John Borshoff, with CFO Craig Barnes stepping in as interim leader while a global search for a successor continues.

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

Beach Energy reported an 8% increase in production to 5.0 million barrels of oil equivalent in Q1 FY26, driven by strong performance in the Otway Basin and Cooper Basin flood recovery. Sales revenue rose 18% to $537 million, supported by two LNG cargoes from the Waitsia Gas Plant, which is now approaching its Ready For Start Up milestone.

Locksley Resources has produced the first 100% American made antimony ingot in decades, validating a fully domestic mine-to-metal supply chain and advancing U.S. critical minerals independence.

Race Oncology showcased compelling preclinical data at ESMO 2025 revealing that their drug RC220, combined with doxorubicin, not only shields the heart from toxicity but also boosts anticancer effects, supporting ongoing clinical trials.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

Prodigy Gold has reported a milestone with over one million ounces of gold in its resource inventory, alongside significant exploration progress and a successful $7.13 million capital raise to fund ongoing development.

Broken Hill Mines reports a milestone September quarter with record mining at Rasp, breakthrough access to the Blackwoods orebody, and strong drilling results at Pinnacles, setting the stage for growth in FY26.

DroneShield Limited reports a staggering 1,091% revenue increase in 3Q25, driven by booming military and civilian counter-drone demand and strategic expansion of manufacturing and AI-powered SaaS offerings.